CARE Ratings to host analyst meet on August 12

1 min read     Updated on 07 Aug 2026, 11:32 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

CARE Ratings Limited announced an analyst meet for August 12, 2026, at EMKAY Confluence 2026 in Mumbai. The session starts at 10:00 AM IST and will focus on publicly available information. An Investor Presentation is available on the company's website for stakeholder review.

powered bylight_fuzz_icon
47671339

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited will host an analyst and institutional investor meet on August 12, 2026, providing stakeholders with an opportunity to discuss the company’s performance and strategic direction. The event is part of the EMKAY Confluence 2026 conference and will take place in Mumbai, offering investors direct access to management insights based on publicly available data.

The meet is scheduled to begin at 10:00 AM IST. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, CARE Ratings Limited issued the intimation to BSE Limited and The National Stock Exchange of India Ltd. on August 7, 2026. The company noted that discussions during the session will be strictly limited to publicly available information.

Event Details

The schedule for the investor interaction is outlined below:

Date Time Organized by Location
August 12, 2026 10:00 AM Onwards EMKAY Confluence 2026 Mumbai

Manoj Kumar CV, Company Secretary & Compliance Officer, signed the disclosure. The company cautioned that the schedule may undergo changes due to exigencies on the part of the investor or the company.

Investor Resources

To assist participants, CARE Ratings Limited has already placed its Investor Presentation on its official website. The document provides a comprehensive overview of the company’s financial health and operational metrics, serving as the basis for the upcoming discussion. Investors are advised to review this material prior to the meet to facilitate informed dialogue with management.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+1.10%+2.44%+4.45%+6.19%+6.86%+147.06%

How might the strategic initiatives outlined in CARE Ratings' investor presentation influence its market share against competitors like CRISIL and ICRA in 2027?

What specific regulatory changes in India's credit rating sector could impact CARE Ratings' revenue models following the EMKAY Confluence discussions?

Will management address any plans for international expansion or acquisitions to diversify revenue streams beyond the domestic Indian market?

CARE Ratings Q1 Results: Net Profit Rises 25% YoY, EBITDA Margin Expands

3 min read     Updated on 07 Aug 2026, 10:53 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

CARE Ratings reported a 24.89% YoY rise in Q1 consolidated net profit to ₹3,299.26 lakh, with revenue from operations growing 18.93% to ₹11,167.95 lakh. EBITDA improved to ₹346M from ₹277M, with EBITDA margin expanding to 31.01% from 29.52%. The core Ratings segment revenue rose to ₹9,871.37 lakh, while standalone net profit grew 16.39% to ₹3,388.36 lakh.

powered bylight_fuzz_icon
47664206

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited reported a consolidated net profit of ₹3,299.26 lakh for the quarter ended June 30, 2026, up 24.89% from ₹2,649.74 lakh in the same period last year. The Mumbai-based credit rating agency saw consolidated revenue from operations rise 18.93% to ₹11,167.95 lakh, driven by an 18.97% increase in its core 'Ratings and related services' segment. EBITDA for the quarter stood at ₹346M, compared to ₹277M in the year-ago period, with EBITDA margin expanding to 31.01% from 29.52% — reflecting improved operating efficiency alongside robust top-line growth.

The Board of Directors, chaired by Managing Director & Group CEO Mehul Pandya, approved the unaudited standalone and consolidated financial results at a meeting held on August 7, 2026. The results were reviewed by B S R & Co. LLP, the statutory auditors of the company, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The figures for the quarter ended March 31, 2026, represent balancing figures between audited full-year data and previously published year-to-date results.

Financial Performance Highlights

Consolidated total income reached ₹12,647.89 lakh, compared to ₹10,760.25 lakh in Q1FY26. Other income contributed ₹1,479.94 lakh, rising from ₹1,369.75 lakh in the prior year quarter. On the expense side, employee benefits expense increased to ₹5,919.52 lakh from ₹5,370.04 lakh, reflecting continued investment in human capital. Total expenses stood at ₹8,150.71 lakh, up from ₹7,016.26 lakh in the same period last year.

Metric: Q1FY27 (₹ Lakh) Q1FY26 (₹ Lakh) Change
Revenue from Operations: 11,167.95 9,390.50 +18.93%
Total Income: 12,647.89 10,760.25 +17.54%
Total Expenses: 8,150.71 7,016.26 +16.17%
Profit Before Tax: 4,497.18 3,743.99 +20.12%
Net Profit: 3,299.26 2,649.74 +24.89%
EBITDA Margin: 31.01% 29.52% +149 bps

Standalone net profit rose 16.39% to ₹3,388.36 lakh from ₹2,911.55 lakh in Q1FY26. Standalone revenue from operations grew 16.54% to ₹8,815.14 lakh. Basic earnings per share (EPS) stood at ₹10.73 on a consolidated basis and ₹11.27 on a standalone basis, compared to ₹8.61 and ₹9.72 respectively in the prior year quarter.

Segment and Operational Details

The 'Ratings and related services' segment generated ₹9,871.37 lakh in revenue, up from ₹8,297.75 lakh in Q1FY26. Segment profit before finance costs and tax for this core business was ₹4,512.16 lakh, compared to ₹3,766.71 lakh in the previous year. The 'Others' segment contributed ₹1,350.51 lakh to revenue but incurred a segment loss of ₹14.36 lakh, contrasting with a loss of ₹146.20 lakh in the same period last year, indicating improved operational efficiency in non-core activities.

Total comprehensive income for the quarter was ₹3,288.97 lakh, attributable to owners of the parent company at ₹3,211.22 lakh. Paid-up equity share capital increased marginally to ₹3,006.04 lakh from ₹2,995.81 lakh, following the allotment of 13,400 equity shares pursuant to the exercise of employee stock options during the quarter. Share-based payment expenses recognized under Ind AS 102 amounted to ₹57.37 lakh in consolidated results and ₹43.85 lakh in standalone results.

What the Numbers Show

The divergence between revenue growth (18.93%) and profit growth (24.89%) suggests improved operating leverage in the first quarter of FY27. The expansion in EBITDA margin to 31.01% from 29.52% further reinforces this trend, indicating that the company is converting a higher proportion of revenue into operating earnings. While employee benefits — typically the largest cost component for rating agencies — rose by 10.23%, they grew at a slower pace than top-line revenue. This indicates that CARE Ratings is generating more revenue per unit of labor cost, likely due to higher ticket sizes or increased efficiency in its ratings workflow. Additionally, the reduction in the loss from the 'Others' segment signals that diversification efforts are stabilizing, contributing positively to overall profitability without dragging down margins.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+1.10%+2.44%+4.45%+6.19%+6.86%+147.06%

Will CARE Ratings sustain its EBITDA margin expansion beyond 31% as competitive pressures from other rating agencies intensify?

How might the continued rise in employee benefits impact long-term profitability if the company needs to hire more analysts to handle growing deal flows?

What specific strategies is CARE Ratings employing to turn the 'Others' segment into a consistent profit contributor rather than just reducing losses?

More News on CARE Ratings

1 Year Returns:+6.86%